{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Vestergaard AL"],"funding":["Frimodt-Heineke Fonden","Dagmar Marshalls Fond","Augustinus Foundation","Danish Medical Association","Axel Muusfeldts Fond","The Toyota Foundation","Aarhus University","Director Emil C.Hertz and Wife Inger Hertz' Foundation","Aase og Ejnar Danielsens Fond"],"pagination":["2145"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11243372"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["16(13)"],"pubmed_abstract":["Vitamin D (vitD) deficiency (25-hydroxy-vitamin D < 50 nmol/L) is common in pregnancy and associated with an increased risk of adverse pregnancy outcomes. High-dose vitD supplementation is suggested to improve pregnancy health, but there is limited knowledge about the effects on placental vitD transport and metabolism and the vitD status of newborns. Comparing the current standard maternal supplementation, 10 µg/day to a 90 µg vitD supplement, we investigated placental gene expression, maternal vitD transport and neonatal vitD status. Biological material was obtained from pregnant women randomized to 10 µg or 90 µg vitD supplements from week 11-16 onwards. Possible associations between maternal exposure, neonatal vitD status and placental expression of the vitD receptor (<i>VDR</i>), the transporters (Cubilin, <i>CUBN</i> and Megalin, <i>LRP2</i>) and the vitD-activating and -degrading enzymes (<i>CYP24A1</i>, <i>CYP27B1</i>) were investigated. Maternal vitD-binding protein (VDBP) was determined before and after supplementation. Overall, 51% of neonates in the 10 µg vitD group were vitD-deficient in contrast to 11% in the 90 µg group. High-dose vitD supplementation did not significantly affect VDBP or placental gene expression. However, the descriptive analyses indicate that maternal obesity may lead to the differential expression of <i>CUBN</i>, <i>CYP24A1</i> and <i>CYP27B1</i> and a changed VDBP response. High-dose vitD improves neonatal vitD status without affecting placental vitD regulation."],"journal":["Nutrients"],"pubmed_title":["Effects of High-Dose Vitamin D Supplementation on Placental Vitamin D Metabolism and Neonatal Vitamin D Status."],"pmcid":["PMC11243372"],"funding_grant_id":["NA","na"],"pubmed_authors":["Andersen MK","Bossow KA","Larsen A","Bor P","Vestergaard AL","Andersen HH"],"additional_accession":[]},"is_claimable":false,"name":"Effects of High-Dose Vitamin D Supplementation on Placental Vitamin D Metabolism and Neonatal Vitamin D Status.","description":"Vitamin D (vitD) deficiency (25-hydroxy-vitamin D < 50 nmol/L) is common in pregnancy and associated with an increased risk of adverse pregnancy outcomes. High-dose vitD supplementation is suggested to improve pregnancy health, but there is limited knowledge about the effects on placental vitD transport and metabolism and the vitD status of newborns. Comparing the current standard maternal supplementation, 10 µg/day to a 90 µg vitD supplement, we investigated placental gene expression, maternal vitD transport and neonatal vitD status. Biological material was obtained from pregnant women randomized to 10 µg or 90 µg vitD supplements from week 11-16 onwards. Possible associations between maternal exposure, neonatal vitD status and placental expression of the vitD receptor (<i>VDR</i>), the transporters (Cubilin, <i>CUBN</i> and Megalin, <i>LRP2</i>) and the vitD-activating and -degrading enzymes (<i>CYP24A1</i>, <i>CYP27B1</i>) were investigated. Maternal vitD-binding protein (VDBP) was determined before and after supplementation. Overall, 51% of neonates in the 10 µg vitD group were vitD-deficient in contrast to 11% in the 90 µg group. High-dose vitD supplementation did not significantly affect VDBP or placental gene expression. However, the descriptive analyses indicate that maternal obesity may lead to the differential expression of <i>CUBN</i>, <i>CYP24A1</i> and <i>CYP27B1</i> and a changed VDBP response. High-dose vitD improves neonatal vitD status without affecting placental vitD regulation.","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 Jul","modification":"2026-04-22T03:24:25.007Z","creation":"2025-04-04T13:41:17.538Z"},"accession":"S-EPMC11243372","cross_references":{"pubmed":["38999892"],"doi":["10.3390/nu16132145"]}}